Management of Herb-Induced Elevated INR in Patients on Warfarin

Introduction to Management

• The American College of Cardiology recommends that for INR between 5 and 9 without bleeding, the next 1-2 doses of warfarin should be omitted and the INR should be rechecked within 24-48 hours, especially when the precipitating factor, such as a herb, is identifiable and reversible 1, 3.

Rationale for Stopping the Herb and Temporarily Holding Warfarin

• Stopping the herb and reassessing INR after 2 days is the correct next step, as simply stopping warfarin without addressing the herb interaction leaves the patient at risk for recurrent INR elevation once warfarin is restarted while the herb is still being consumed 1, 2.

Management of Elevated INR

• If INR is 5-9 without bleeding and the patient has no increased bleeding risk, simply holding warfarin and monitoring is recommended 3, 2.
• If INR is 5-9 and the patient has increased bleeding risk, administering oral vitamin K₁ 1-2.5 mg is suggested 3, 6, 2.
• If INR is ≥9 without bleeding, administering oral vitamin K₁ 3-5 mg is advised 3, 6.

Follow-Up and Resumption of Warfarin

• Rechecking INR within 24-48 hours after holding warfarin and stopping the herb is crucial, and if INR has normalized (2.0-3.0), resuming warfarin at a slightly reduced dose (approximately 10-15% lower than previous weekly total) is recommended 3, 2.

Education and Monitoring

• Educating the patient about herb-warfarin interactions to prevent recurrence is essential 1.
• Resuming regular INR monitoring (initially every 1-2 weeks, then monthly once stable) is necessary 4.

Avoiding Common Pitfalls

• Administering unnecessary vitamin K can lead to warfarin resistance and difficulty re-establishing therapeutic anticoagulation, and thus should be avoided unless necessary 5, 6, 2.
• Switching anticoagulants prematurely without a valid indication, such as failure of warfarin therapy or significant side effects, is not recommended 1.